Increasing Diagnosis Rates and Growing Use of Key Agents Such as Pfizer's Lyrica Will Drive Eight Percent Annual Growth in the Fibromyalgia Drug Market Through 2018
WALTHAM, Mass., July 13 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that increased use of key agents such as Pfizer's Lyrica, Eli Lilly/Boehringer Ingelheim's Cymbalta/Xeristar/Ariclaim and Forest Labora...
VIDEO from Medialink, the National Fibromyalgia Association and Pfizer: The Painful Truth about Fibromyalgia
NFA President and Kim Dupree Jones, PhD, FNP Join Together to Raise Awareness of Common, But Often Overlooked Chronic Pain Condition
ANAHEIM, Calif., May 12 /PRNewswire/ -- Fibromyalgia
is often called an "invisible" illness because the people who have it typically do not look sick. However,...
Practicing Clinicians Exchange Forms Partnership With National Fibromyalgia Association
STAMFORD, Conn., Feb. 25 /PRNewswire/ -- Practicing Clinicians Exchange (PCE) has formed a partnership with the National Fibromyalgia
Association (NFA) to provide continuing education programs to nurse practitioners (NPs) and physician assistants (PAs) throughout the United States in 2009.
Certain Antidepressants Ease Fibromyalgia Symptoms
Tricyclic medications helped with pain, fatigue and depression, study shows
TUESDAY, Jan. 13 (HealthDay News) -- Antidepressants may help people living with the chronic pain of fibromyalgia
experience fewer symptoms and improve their quality of life, new research shows.
The study, l...
Scans Reveal Brain Abnormalities in Fibromyalgia Patients
Finding offers more evidence that the condition is 'real,' researchers say
MONDAY, Nov. 3 (HealthDay News) -- Researchers have detected abnormalities in the brains of people with fibromyalgia, a complex, chronic condition characterized by muscle pain and fatigue.
"We showed in our s...
Important Information on Fibromyalgia and Access to Treatments
Examining the Foundation of Patient Driven Medicine
Note: September is Pain Awareness Month
SACRAMENTO, Calif., Sept. 2 /PRNewswire-USNewswire/ -- Insurance
companies are denying Fibromyalgia
patients proper access to treatments for
their chronic pain condition. Doctors are having a diffic...
Pain in fibromyalgia is linked to changes in brain molecule
ANN ARBOR, Mich. Researchers at the University of Michigan Health System have found a key linkage between pain and a specific brain molecule, a discovery that lends new insight into fibromyalgia, an often-baffling chronic pain condition.
In patients with fibromyalgia, researchers found, pain d...
Aquatic Exercises May Ease Fibromyalgia
Exercise in heated pool brought relief from chronic pain, study found
FRIDAY, Feb. 22 (HealthDay News) -- Regular exercise in a heated swimming pool can benefit people with the common, painful condition fibromyalgia, a new study suggests.
Symptoms of fibromyalgia
include chronic an...
Exercise Eases Fibromyalgia Symptoms: Study
Biggest beneficiaries were women who also received training to manage the condition
MONDAY, Nov. 12 (HealthDay News) -- Exercise may seem best at preventing illness rather than treating it, but a new study suggests that low-impact physical activity could make an immediate difference fo...
Effective Treatment for Fibromyalgia Featured on Oprah Winfrey Show 'You Don't Have to Live With That Agony!'
CHICAGO, Nov. 6 /PRNewswire/ -- On yesterday's Oprah Winfrey Show,
themed "How to Turn Back Time," New York-Presbyterian cardiothoracic
surgeon Mehmet Oz, MD, offered anti-aging strategies from his new book YOU:
Staying Young-The Owner's Manual for Extending Your Warranty. In the discussion, ...
Fibromyalgia in Medical Technology
Jazz Pharmaceuticals and UCB Announce Second Phase III Study of Sodium Oxybate in Patients With Fibromyalgia Meets Primary Endpoints
Preliminary top-line results of second Phase III study show highly significant decreases in pain and fatigue and improved daily function in fibromyalgia
patients and confirm results from the first Phase III study
PALO ALTO, Calif., and BRUSSELS, June 24 /PRNewswire-FirstCall/ -- press releas...
New Global Survey Exposes Considerable Burden of Fibromyalgia Including Potential Economic Impact
PARIS, June 13 /PRNewswire/ --
- Lack of Physician Education May Contribute to Problem
A new global survey of fibromyalgia
patients and physicians shows that
fibromyalgia, a chronic widespread pain condition, results in poor quality
of life and poses a financial burden on patients often re...
Milnacipran Demonstrated Significant Improvement in Pain and the Core Symptoms of Fibromyalgia Syndrome, Data Show
NEW YORK, Nov. 8 /PRNewswire/ -- Total daily dosages of milnacipran 100
mg and 200 mg demonstrated statistically significant and clinically
meaningful improvements in both pain and other core symptoms associated
syndrome (FMS), according to Phase III data presented
this week ...
New Data Suggest Cymbalta(R) Reduced Pain in Fibromyalgia Patients With and Without Depression
INDIANAPOLIS, Aug. 21 /PRNewswire-FirstCall/ -- New data suggest that
patients with fibromyalgia
treated with 60mg or 120mg of Cymbalta(R)
(duloxetine HCl) experienced greater reduction in pain severity beginning
one week after starting duloxetine than those taking placebo (sugar pill),
Data Suggest Sodium Oxybate Significantly Improves Pain and the Core Symptoms of Fibromyalgia
PALO ALTO, Calif., June 15 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals' (Nasdaq: JAZZ ) sodium oxybate (JZP-6) demonstrated statistically significant and clinically meaningful improvement in pain and the core symptoms associated with fibromyalgia, according to Phase III data presented last we...
Jazz Pharmaceuticals, Inc. Completes Enrollment in Second of Two Phase III Clinical Trials of Sodium Oxybate to Treat Fibromyalgia
PALO ALTO, Calif., Jan. 13 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals,
Inc. (Nasdaq: JAZZ ) today announced completion of enrollment in the second of
two Phase III pivotal clinical trials of JZP-6 (sodium oxybate) for the
treatment of fibromyalgia.
"Completion of enrollment in thi...
Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study of Milnacipran for the Management of Fibromyalgia
NEW YORK and SAN DIEGO, Dec. 8, 2008 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX ) and Cypress Bioscience, Inc. (Nasdaq: CYPB ) today announced positive top-line results from a 1,025 patient, multicenter, double-blind, placebo-controlled phase III study of milnacipran for th...
Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia
PRELIMINARY TOP LINE RESULTS OF FIRST PHASE III TRIAL SHOW SIGNIFICANT
DECREASES IN PAIN AND FATIGUE, AND IMPROVEMENT IN DAILY FUNCTION, IN
PALO ALTO, Calif., and BRUSSELS, Belgium, Nov. 20 /PRNewswire-FirstCall/
-- Jazz Pharmaceutica...
Jazz Pharmaceuticals, Inc. Announces Final Patient Has Completed Phase III Clinical Trial of Sodium Oxybate to Treat Fibromyalgia
PALO ALTO, Calif., Sept. 11 /PRNewswire-FirstCall/ -- Jazz
Pharmaceuticals, Inc. (Nasdaq: JAZZ ) today announced that the final patient
has completed participation in the first Phase III pivotal clinical trial
of JZP-6 (sodium oxybate) for the treatment of fibromyalgia.
The JZP-6 Phase III ...
Jazz Pharmaceuticals, Inc. Completes Enrollment in First of Two Phase III Clinical Trials of Sodium Oxybate to Treat Fibromyalgia
PALO ALTO, Calif., June 2 /PRNewswire-FirstCall/ -- Jazz
Pharmaceuticals, Inc. (Nasdaq: JAZZ ) today announced completion of
enrollment in the first of two Phase III pivotal clinical trials of JZP-6
(sodium oxybate) for the treatment of fibromyalgia.
"Completion of enrollment in this trial ...
Fibromyalgia in Medical Dictionary
, meaning muscle and connective tissue pain, is a medically unexplained syndrome characterized by chronic widespread pain and a heightened and painful response to pressure (allodynia). Other core symptoms are... Fibromyalgia
affects an estimated 5.8 million Americans. ...
... that affects the liver. ... The syndrome occurs in about one in every 70,000 births 1 and is equally common ... Get information on living with fibromyalgia
and chronic fatigue syndrome , including life-style and nutritional changes, exercise guidelines, and coping emotionally. Down syndrome ...
..., central portion... The disks are protective shock-absorbing pads between the bones of the spine. ... Next: Slipped Disk Causes " Do You Have fibromyalgia
Pain? ... Sciatica (pronounced sigh-AT-ih-ka) is low back pain combined with a pain ... Lumbar (Intervertebral) Disk Disorders " Lumbar dis...
...oints. Definition: Rheumatism or Rheumatic disorder is a non-specific term for medical ... Some countries use the word Rheumatism to describe fibromyalgia
syndrome. ... Acute Rheumatism Or Rheumatic Fever is the name given to a disease having for ... The acute rheumatism of childhood differs...
...bout Pain Management . Physical pain , whether from injury, surgery or another cause, is among the most common medical complaints. There ... fibromyalgia
is a chronic syndrome characterized by diffuse or specific muscle, joint or bone pain , fatigue, and a wide range of other symptoms. It is not ...
... thermoreceptor c- fibers sensitized to norepinephrine . ... It does not address the norepinephrine dysfunction. ... Learn about the potential fibromyalgia
treatment milnacipran, including how it works, what side effects it can have, ... serotonin and norepinephrine . ... norepinephrine synony...
...yalgia that is not caused by muscle strain can be present in a ... fibromyalgia
information and education from health care professionals at Oregon Health &...rome ... Are you considering using herbs and supplements to treat your fibromyalgia
symptoms? ... was associated with a serious condition called eosinophilia-...
...dition that ... Muscle aches from overuse and fibromyalgia
often respond well to massage. ... One common...dition that ... Muscle aches from overuse and fibromyalgia
often respond well to massage. ... Conditions...dition that ... Muscle aches from overuse and fibromyalgia
often respond well to massage. ... ...
...terstitial cystitis — Comprehensive overview covers symptoms, causes, treatment, self-care of this painful bladder inflammation. The National fibromyalgia
Association's mission is to develop and execute ... Interstitial Cystitis (pronounced in-tur-STI-shul sis-TY-tis), also known as ... ...
...m " fibrositis " is therefore considered a ... fibromyalgia
is a complex syndrome with no known cause or cur... is not an inflammatory disorder of ... About fibromyalgia fibromyalgia
is a complex syndrome with no known cause or cur...
Fibromyalgia in Biological News
What a sleep study can reveal about fibromyalgia
Research engineers and sleep medicine specialists from two Michigan universities have joined technical and clinical hands to put innovative quantitative analysis, signal-processing technology and computer algorithms to work in the sleep lab. One of their recent findings is that a new approach to ...
Chemical in blood may explain susceptibility to bladder pain
...se the underlying cause of the disease is unknown.
Buffington plans to test human samples from patients diagnosed with irritable bowel syndrome and fibromyalgia
to see if the same biomarker is associated with these chronic pain disorders as well. These disorders, like IC, are categorized as what are known as m...
Is cherry juice a new 'sports drink?'
...ch suggests cherries could affect inflammation related to heart disease, arthritis and may even help maintain muscle strength for those suffering from fibromyalgia
(a common, chronic widespread pain disorder), according to a second study presented by the same researchers at the ACSM conference.
It's Easy to...
U. Iowa study finds biological link between pain and fatigue
...ls a biological link between pain and fatigue and may help explain why more women than men are diagnosed with chronic pain and fatigue conditions like fibromyalgia
and chronic fatigue syndrome.
Working with mice, the researchers, led by Kathleen Sluka, Ph.D., professor in the Graduate Program in Physical Thera...
Brain differences could explain why males and females experience pain relief differently
...Thus, the management of pain has become one of the highest priorities in health care. Chronic pain from inflammatory conditions such as arthritis and fibromyalgia
are the most prevalent and pervasive forms of chronic pain.
Clinical evidence suggests that women are much more likely to experience chronic forms...
Fibromyalgia in Biological Technology
Fralex reaches 100th patient milestone in fibromyalgia study
- Interim analysis results expected in Q3 2008 -
TORONTO, March 10 /PRNewswire-FirstCall/ - Fralex Therapeutics Inc.
(TSX:FXI) ("Fralex" or the "Company"), a medical technology company
developing a non-invasive neuromodulation device, today announced the
randomization of the 100th ...
Forest and Cypress Announce Submission of New Drug Application for Milnacipran for the Treatment of Fibromyalgia Syndrome
NEW YORK and SAN DIEGO, Dec. 31 /PRNewswire-FirstCall/ -- Forest
Laboratories, Inc. (NYSE: FRX ) and Cypress Bioscience, Inc. (Nasdaq: CYPB )
announced that they have recently submitted a New Drug Application (NDA) to
the U.S. Food and Drug Administration (FDA) for milnacipran, a unique
Sosei Announces Completion of Phase II Trial of AD 337 in Fibromyalgia Syndrome
TOKYO, September 18 /PRNewswire-FirstCall/ -- Sosei Group Corporation
("Sosei"; TSE Mothers Index: 4565), the biopharmaceutical company, today
announces that AD 337, an enantiomer of an approved, centrally acting,
non-opioid, analgesic, has completed a Phase II proof of principle trial
European CHMP Adopts Negative Opinion on Cymbalta for the Treatment of Fibromyalgia
INDIANAPOLIS, Oct. 24 /PRNewswire-FirstCall/ -- The Committee for
Medicinal Products for Human Use (CHMP) of the European Medicines Agency
(EMEA) has adopted a negative opinion on a Cymbalta(R) (duloxetine
hydrochloride) application for the treatment of fibromyalgia.
"Eli Lilly and Company a...
Jazz Pharmaceuticals Announces Reduction in Force to Reflect Streamlined Operations
...tly markets and sells XYREM(R) (sodium oxybate) and
LUVOX CR(R). The company will continue development of JZP-6 (sodium oxybate)
for the treatment of fibromyalgia
syndrome. In a recent press release, the
company announced positive top-line results from the first of two pivotal
Phase III clinical trials of JZP-6...
Bioenergy D-Ribose Achieves Highest Safety Standard
...ose also has been shown to
assist patients with compromised heart function and is also widely used by
patients with Chronic Fatigue Syndrome (CFS) and fibromyalgia
Bioenergy, Inc. ( http://www.bioenergy.com ) is a privately held,
Minneapolis-based life sciences company whose core technology lies in...
WWMR Announces Pain Clinic Physicians' Most Appreciated Companies: Pfizer, Eli Lilly and Endo Pharmaceuticals
...nd its line of
pain-related, multi-client Enhanced Perspective publications, with its 2008
U.S. Neuropathic Pain Report, featuring two new chapters -- fibromyalgia
Neuropathic Cancer Pain. Two additional pain-related reports are scheduled to
be available soon: Cancer Pain in December 2008 and Back Pain in Ja...
From Pain to Unexpected Fame: One Woman's Journey to Know Fibro
...elp People Living with fibromyalgia
INDIANAPOLIS, Oct. 27 /PRNewswire-FirstCall/ -... before she finally received a formal
diagnosis of fibromyalgia
at age 31.
Along the way, Beck developed coping ... and Company (NYSE: LLY ), provides
information, symptom management tools, practical
Gerson Lehrman Group and BIO Collaborate to Identify Scientific Expertise for the Seventh Annual BIO Investor Forum
...executives from public and
private equity biotechnology companies to discuss:
-- Congestive Heart Failure -- Cystic Fibrosis -- Epilepsy -- fibromyalgia
-- Lung Cancer -- Neurodegenerative Diseases -- Novel Solid Tumor Targets -- Osteoporosis -- Pre-ASH Primer "With the financial markets exp...
US Neuropathic Pain Market Value Doubles to $5 Billion by 2018
...neuropathic pain in 2004. The additional June 2008 approval of
Cymbalta for fibromyalgia
will spur penetration of this prevalent
Based on a decade of e...l slow between 2013 and 2018 as
Lyrica and Cymbalta patents expire, and the fibromyalgia
becomes saturated. Additional launch of novel compounds ...